Search research articles
Contact Us
Filters
Showing results (31-40 of 87) with videos related to
Page
of 9
Sort By:
The Journal of Investigative Dermatology
|
January 29, 2014
Decreased expression of the chromatin remodeler ATRX associates with melanoma progression
Zulekha A Qadeer, Sara Harcharik, David Valle-Garcia, et al.
Genes & Development
|
May 14, 2024
H2A.Z chaperones converge on E2F target genes for melanoma cell proliferation
Sina Jostes, Chiara Vardabasso, Joanna Dong, et al.
Developmental Cell
|
June 25, 2019
Epigenetic Compensation Promotes Liver Regeneration
Shuang Wang, Chi Zhang, Dan Hasson, et al.
NAR Cancer
|
August 14, 2025
SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells
Tzofit Elbaz Biton, Michal Feldman, Tomer Davidy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2012
H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence
Agustin Chicas, Avnish Kapoor, Xiaowo Wang, et al.
The Journal of Biological Chemistry
|
November 7, 2013
Mitogen-activated protein kinase signaling mediates phosphorylation of polycomb ortholog Cbx7
Hsan-au Wu, Jeremy L Balsbaugh, Hollie Chandler, et al.
Epigenetics
|
April 1, 2016
ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment
David Valle-García, Zulekha A Qadeer, Domhnall S McHugh, et al.
The Journal of Investigative Dermatology
|
June 3, 2015
Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAF(V600E) Melanoma
Shira Y Wieder, Madhavika N Serasinghe, Julie C Sung, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 20, 2021
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study
Peter Rieckmann, Robert Zivadinov, Alexey Boyko, et al.
Molecular Cancer Research : MCR
|
April 12, 2022
Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma
David A Schoenfeld, Royce Zhou, Sakellarios Zairis, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 87) with videos related to
Sort By:
Page
of 9
The Journal of Investigative Dermatology
|
January 29, 2014
Decreased expression of the chromatin remodeler ATRX associates with melanoma progression
Zulekha A Qadeer, Sara Harcharik, David Valle-Garcia, et al.
Genes & Development
|
May 14, 2024
H2A.Z chaperones converge on E2F target genes for melanoma cell proliferation
Sina Jostes, Chiara Vardabasso, Joanna Dong, et al.
Developmental Cell
|
June 25, 2019
Epigenetic Compensation Promotes Liver Regeneration
Shuang Wang, Chi Zhang, Dan Hasson, et al.
NAR Cancer
|
August 14, 2025
SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells
Tzofit Elbaz Biton, Michal Feldman, Tomer Davidy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2012
H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence
Agustin Chicas, Avnish Kapoor, Xiaowo Wang, et al.
The Journal of Biological Chemistry
|
November 7, 2013
Mitogen-activated protein kinase signaling mediates phosphorylation of polycomb ortholog Cbx7
Hsan-au Wu, Jeremy L Balsbaugh, Hollie Chandler, et al.
Epigenetics
|
April 1, 2016
ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment
David Valle-García, Zulekha A Qadeer, Domhnall S McHugh, et al.
The Journal of Investigative Dermatology
|
June 3, 2015
Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAF(V600E) Melanoma
Shira Y Wieder, Madhavika N Serasinghe, Julie C Sung, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 20, 2021
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study
Peter Rieckmann, Robert Zivadinov, Alexey Boyko, et al.
Molecular Cancer Research : MCR
|
April 12, 2022
Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma
David A Schoenfeld, Royce Zhou, Sakellarios Zairis, et al.
Page
of 9